AJP - Regu Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 275: R1822-R1832, 1998;
0363-6119/98 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Woods, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Woods, R. L.
Vol. 275, Issue 6, R1822-R1832, December 1998

Vasoconstrictor actions of atrial natriuretic peptide in the splanchnic circulation of anesthetized dogs

Robyn L. Woods

Baker Medical Research Institute, Prahran, Victoria 3181, Australia

Intravenous atrial natriuretic peptide (ANP) usually results in splanchnic vasoconstriction in humans or experimental animals that is accompanied by falls in blood pressure and/or cardiac output. To determine direct in vivo effects in the present study, ANP was infused (12 ng · kg-1 · min-1) directly into the mesenteric (iMA) and hepatic (iHA) arterial beds of anesthetized dogs, thereby minimizing changes in blood pressure. Over the first 2 min of iMA infusion, rate of change in mesenteric vascular resistance was 19.6 ± 5.4 mmHg · l-1 · min-1/min, reaching a maximum increase in resistance of 22 ± 4% compared with baseline after ~10 min. There was no evidence of vasodilatation at any stage. The mesenteric response was similar whether ANP was infused iMA, iHA, or via the femoral vein (30 ng · kg-1 · min-1). In contrast, hepatic vasoconstrictor response to ANP infusion iHA or into the portal vein was only evident after ~5 min, reaching a maximum increase in hepatic vascular resistance of 11 ± 6% after ~15 min iHA infusion. When preinfused through the gut vasculature (iMA), ANP increased hepatic vascular resistance earlier and reached similar levels (14 ± 3%), despite a lower arterial concentration of ANP. It is proposed that a vasoconstrictor agent from the intestinal circulation contributed to ANP-induced splanchnic vasoconstriction.

atrial natriuretic factor; blood flow; fractional extraction; hepatic artery; hepatic autoregulation; intestinal tract; in vivo; mesenteric artery; vasoconstriction; vascular resistance


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
H. Ehmke
Inducing vasoconstriction by activating guanylyl cyclase
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1376 - R1377.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. S. Andrew and S. Kaufman
Guanylyl cyclase mediates ANP-induced vasoconstriction of murine splenic vessels
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2003; 284(6): R1567 - R1571.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. L. Woods and M. J. M. Jones
Atrial, B-type, and C-type natriuretic peptides cause mesenteric vasoconstriction in conscious dogs
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1443 - R1452.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online